You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Early-stage tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early-stage Breast Cancer Trial (Huaier granule)

Not yet recruiting
  • Early-stage Breast Cancer
  • Huaier granule
  • (no location specified)
May 12, 2023

Cancer Trial in Taipei (Hitachi's Heavy Ion Beam Therapy System HyBEAT)

Completed
  • Cancer
  • Hitachi's Heavy Ion Beam Therapy System HyBEAT
  • Taipei, Taiwan
    Cancer Center, Taipei Veterans General Hospital
Mar 9, 2023

GAMAD for Early-stage HCC Based on Circulating Tumor DNA

Not yet recruiting
  • Hepatocellular Carcinoma
  • GAMAD
  • (no location specified)
Nov 22, 2022

Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Pembrolizumab 25 mg/ml
  • Paclitaxel injection
  • (no location specified)
Oct 11, 2023

Early-stage Lung Cancer Trial in Nijmegen (99mTc-nanocolloid, ICG)

Recruiting
  • Early-stage Lung Cancer
  • 99mTc-nanocolloid
  • ICG
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Dec 9, 2022

Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy

Recruiting
  • Breast Neoplasms
  • Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Nov 1, 2022

Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)

Completed
  • Cancer, Treatment-Related
  • +3 more
  • cryoablation
  • Roma, Italy
    Sapienza University of Rome
Feb 13, 2023

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

NSCLC Trial in Beijing

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Beijing, China
      Peking University People's Hospital
    Apr 23, 2022

    Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Pulmonary Artery-First Surgical Technique
    • Biospecimen Collection
    • (no location specified)
    Aug 15, 2022

    Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)

    Not yet recruiting
    • Endometrial Carcinoma Stage I
    • Atypical Endometrial Hyperplasia
    • No intervention
    • (no location specified)
    Dec 3, 2022

    COGNITION: Genomics-Guided Precision Oncology in Early High-Risk

    Recruiting
    • Early-Stage Breast Cancer
    • Neoadjuvant Therapy
    • Genomic Profiling / Sequencing
    • Berlin, Germany
    • +4 more
    Jun 19, 2023

    Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)

    Not yet recruiting
    • Mycosis Fungoides
    • Cutaneous T Cell Lymphoma
    • Low-dose total-skin electron-beam therapy
    • Phototherapy
    • (no location specified)
    Jan 24, 2022

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    ctDNA Monitoring in Early Breast Cancer

    Recruiting
    • Breast Cancer
      • Chongqing, Chongqing, China
        Army Medical Center of PLA, China
      Mar 15, 2022

      Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

      Not yet recruiting
      • Early-stage Breast Cancer
      • Atezolizumab 1200 mg in 20 ML Injection
      • +5 more
      • Heidelberg, Baden-Wuerttemberg, Germany
        National Center for Tumor Diseases
      Sep 13, 2022

      Nasopharyngeal Carcinoma Trial in Beijing (intensity-modulated radiotherapy (IMRT) with reduced-volume, Cisplatin (DDP))

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • intensity-modulated radiotherapy (IMRT) with reduced-volume
      • Cisplatin (DDP)
      • Beijing, China
        Cancer hospital, Chinese Academy of Medical Sciences
      Nov 22, 2021

      Breast Cancer, Early-Onset Trial in United States (Neoadjuvant chemo administered before surgical extraction of a tumor,

      Active, not recruiting
      • Breast Cancer, Early-Onset
      • Neoadjuvant chemotherapy administered before surgical extraction of a tumor
      • Observational
      • Elizabeth, New Jersey
      • +11 more
      Nov 29, 2022

      Circulating Tumor Cell Phenotype Surveillance in Breast Cancer

      Recruiting
      • Breast Neoplasms
      • +2 more
      • CTC detection
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Apr 5, 2022

      Tongue Cancer, Tongue Cancer TNM Staging Primary Tumor (T) T1, Tongue Cancer TNM Staging Primary Tumor (T) T2 Trial in Seoul,

      Recruiting
      • Tongue Cancer
      • +5 more
      • 1.5 cm surgical safety margin for cT1-2N0 oral tongue cancers
      • 1.0 cm surgical safety margin for cT1-2N0 oral tongue cancers
      • Seoul, Korea, Republic of
      • +3 more
      May 3, 2022

      Adenocarcinoma of Lung Trial in United States (NovoTTF-200T System)

      Not yet recruiting
      • Adenocarcinoma of Lung
      • NovoTTF-200T System
      • Basking Ridge, New Jersey
      • +6 more
      Mar 3, 2023

      HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

      Active, not recruiting
      Has Results
      • HER-2 Positive Breast Cancer
      • +3 more
      • Boston, Massachusetts
      • +3 more
      Mar 4, 2022

      Lung Cancer, Surgery, Circulating Tumor Cell Trial in Amsterdam, Leiden (Cetuximab)

      Not yet recruiting
      • Lung Cancer
      • +2 more
      • Amsterdam, Netherlands
      • +1 more
      Oct 19, 2021

      NSCLC Stage I Trial in Shanghai (traditional Chinese medicine and ablation in the primary tumor sites, ablation)

      Recruiting
      • Non-small Cell Lung Cancer Stage I
      • traditional Chinese medicine and ablation in the primary tumor sites
      • ablation
      • Shanghai, Shanghai, China
        Shanghai 10th People's Hospital
      Oct 27, 2021

      Early-stage Breast Cancer, Hormone Receptor Positive Tumor Trial in Sydney (Letrozole, Letrozole and Prometrium, Tamoxifen and

      Recruiting
      • Early-stage Breast Cancer
      • Hormone Receptor Positive Tumor
      • Sydney, New South Wales, Australia
        St Vincent's Hospital
      Sep 23, 2021